Notice2023-07038
Solicitation of Nominations for Appointment to the Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 5, 2023
Issuing agencies
Health and Human Services Department
Abstract
The Office of the Assistant Secretary for Health (OASH) is seeking nominations for membership on the Advisory Committee on Blood and Tissue Safety and Availability (referred to as ACBTSA and/or the Committee). This announcement is to solicit nominations of qualified candidates to five public member positions on the ACBTSA. The ACBTSA is a federal advisory committee within the U.S. Department of Health and Human Services (HHS). Qualified individuals will be nominated to the Secretary of Health and Human Services for consideration of appointment as members of the ACBTSA. Members are invited to serve on the Committee for up to four-year terms. The Committee was established to provide advice to the Secretary on a range of policy issues related to blood, blood products, and tissues. The functions of the Committee are solely advisory in nature.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 65 (Wednesday, April 5, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 65 (Wednesday, April 5, 2023)]
[Notices]
[Pages 20173-20174]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-07038]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Solicitation of Nominations for Appointment to the Advisory
Committee on Blood and Tissue Safety and Availability (ACBTSA)
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, U.S. Department of Health and Human Services.
[[Page 20174]]
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Office of the Assistant Secretary for Health (OASH) is
seeking nominations for membership on the Advisory Committee on Blood
and Tissue Safety and Availability (referred to as ACBTSA and/or the
Committee). This announcement is to solicit nominations of qualified
candidates to five public member positions on the ACBTSA. The ACBTSA is
a federal advisory committee within the U.S. Department of Health and
Human Services (HHS). Qualified individuals will be nominated to the
Secretary of Health and Human Services for consideration of appointment
as members of the ACBTSA. Members are invited to serve on the Committee
for up to four-year terms. The Committee was established to provide
advice to the Secretary on a range of policy issues related to blood,
blood products, and tissues. The functions of the Committee are solely
advisory in nature.
DATES: Nominations for membership on the ACBTSA must be received no
later than 5:00 p.m. (ET), May 5, 2023. Packages received after this
time will not be considered for the current membership cycle.
ADDRESSES: All nominations should be electronically mailed in one email
to <a href="/cdn-cgi/l/email-protection#8dcccecfd9decccde5e5fea3eae2fb"><span class="__cf_email__" data-cfemail="01404243555240416969722f666e77">[email protected]</span></a>. Please include in the subject line of the email:
ACBTSA Application.
FOR FURTHER INFORMATION CONTACT: James Berger, Designated Federal
Officer for the ACBTSA; Office of Infectious Disease and HIV/AIDS
Policy, Office of the Assistant Secretary for Health, Department of
Health and Human Services, Tower Building, 1101 Wootton Parkway,
Rockville, MD 20852. Email: <a href="/cdn-cgi/l/email-protection#adeceeeff9feecedc5c5de83cac2db"><span class="__cf_email__" data-cfemail="3a7b79786e697b7a525249145d554c">[email protected]</span></a>. Phone: 202-795-7608.
Additional information about ACBTSA can be obtained by accessing the
Committee's website at <a href="https://www.hhs.gov/oidp/advisory-committee/blood-tissue-safety-availability/index.html">https://www.hhs.gov/oidp/advisory-committee/blood-tissue-safety-availability/index.html</a>.
SUPPLEMENTARY INFORMATION: ACBTSA is authorized under 42 U.S.C. 217a,
section 222 of the Public Health Service (PHS) Act, as amended. The
Committee is governed by the provisions of the Federal Advisory
Committee Act (FACA), Public Law 92-463, as amended, which sets forth
standards for the formation and use of advisory committees. The ACBTSA
advises, assists, consults with, and makes policy recommendations to
the Secretary, through the Assistant Secretary for Health, regarding
broad responsibilities related to the safety of blood, blood products,
tissues, and organs. For solid organs and blood stem cells, the
Committee's work is limited to policy issues related to donor derived
infectious disease complications of transplantation.
The Advisory Committee consists of up to 29 members, including the
voting and non-voting members and the Chair and Vice Chair or Co-
Chairs. The Committee consists of not more than 23 voting members; 14
public members, including the Chair, and nine (9) individuals
designated to serve as official representative members. The public
members are selected from state and local organizations, patient
advocacy groups, provider organizations, academic researchers,
ethicists, physicians, surgeons, scientists, risk communication
experts, consumer advocates, and from among communities of persons who
are frequent recipients of blood or blood products or who have received
tissues or organs. The nine individuals who are appointed as official
representatives are selected to serve the interests of the blood, blood
products, tissue and organ professional organizations or business
sectors. The representative members are selected from the following
groups: The AABB (formerly the American Association of Blood Banks);
American Association of Tissue Banks; Eye Bank Association of America;
Association of Organ Procurement Organizations; and one of either the
American Red Cross or America's Blood Centers. The Committee
composition can include additional representation from either the
plasma protein fraction community or a trade organization; a
manufacturer of blood, plasma, or other tissue/organ test kits; a
manufacturer of blood, plasma or other tissue/organ equipment; a major
hospital organization; or a major hospital accreditation organization.
All voting members are appointed by the Secretary or designee.
Public voting members are classified as special government employees
(SGEs) and are subject to government ethics rules. Pursuant to an
advance written agreement, SGE voting members shall receive no stipend
from the federal government for the services they perform during their
tenure on the Committee. However, the SGE voting members are entitled
to receive per diem and reimbursement for travel expenses incurred for
attending meetings of the Advisory Committee.
Nominations
Nominations are being sought for individuals who have expertise and
qualifications necessary to contribute to the accomplishment of the
ACBTSA's objectives. The U.S. Department of Health and Human Services
policy stipulates that committee membership be balanced in terms of
points of view represented and the committee's function. Appointments
shall be made without discrimination on the basis of age, race,
ethnicity, sexual orientation, gender identity, disability, veteran
status, and cultural or religious status. In order to help ensure
diverse groups and points of view are represented on the committee,
nominees may provide this information when applying. Nominees must be
U.S. citizens and cannot be full-time employees of the U.S. Government.
Public members of the Committee are Special Government Employees
(SGEs), requiring the filing of financial disclosure reports at the
beginning and annually during their terms. Individuals who are selected
for appointment will be required to provide detailed information
regarding their financial interests and must receive annual ethics
training. Candidates should submit the following items to be considered
of appointment:
<bullet> Current curriculum vitae or resume, including complete
contact information (telephone numbers, mailing address, email
address).
<bullet> A letter of interest or personal statement from the
nominee stating how their expertise would inform the work of ACBTSA
(300 words or fewer).
<bullet> Nominees are invited to identify any or some of the
following: race, ethnicity, sexual orientation, gender identity,
disability, veteran status and cultural or religious status. This is
not mandatory for a complete application.
Individuals can nominate themselves for consideration of
appointment to the Committee. All nominations must include the required
information in one email sent to <a href="/cdn-cgi/l/email-protection#a9e8eaebfdfae8e9c1c1da87cec6df"><span class="__cf_email__" data-cfemail="34757776606775745c5c471a535b42">[email protected]</span></a> with the subject line,
``ACBTSA Application.'' Incomplete nomination applications will not be
processed for consideration.
Dated: March 13, 2023.
James J. Berger,
Senior Advisor for Blood and Tissue Policy, Designated Federal Officer,
Advisory Committee on Blood and Tissue Safety and Availability, Office
of the Assistant Secretary for Health, Department of Health and Human
Services.
[FR Doc. 2023-07038 Filed 4-4-23; 8:45 am]
BILLING CODE 4150-41-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on April 5, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.